Global Neuropsychiatric Disorders and Treatment Market Research Report 2023

Report ID: 1988708 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Neuropsychiatric Disorders and Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Drug Treatment
        1.2.3 Shock Treatment
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Neuropsychiatric Disorders and Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Research Centres
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Neuropsychiatric Disorders and Treatment Market Perspective (2017-2028)
    2.2 Neuropsychiatric Disorders and Treatment Growth Trends by Region
        2.2.1 Neuropsychiatric Disorders and Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Neuropsychiatric Disorders and Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Neuropsychiatric Disorders and Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Neuropsychiatric Disorders and Treatment Market Dynamics
        2.3.1 Neuropsychiatric Disorders and Treatment Industry Trends
        2.3.2 Neuropsychiatric Disorders and Treatment Market Drivers
        2.3.3 Neuropsychiatric Disorders and Treatment Market Challenges
        2.3.4 Neuropsychiatric Disorders and Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Neuropsychiatric Disorders and Treatment Players by Revenue
        3.1.1 Global Top Neuropsychiatric Disorders and Treatment Players by Revenue (2017-2022)
        3.1.2 Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Neuropsychiatric Disorders and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Neuropsychiatric Disorders and Treatment Revenue
    3.4 Global Neuropsychiatric Disorders and Treatment Market Concentration Ratio
        3.4.1 Global Neuropsychiatric Disorders and Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Neuropsychiatric Disorders and Treatment Revenue in 2021
    3.5 Neuropsychiatric Disorders and Treatment Key Players Head office and Area Served
    3.6 Key Players Neuropsychiatric Disorders and Treatment Product Solution and Service
    3.7 Date of Enter into Neuropsychiatric Disorders and Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Neuropsychiatric Disorders and Treatment Breakdown Data by Type
    4.1 Global Neuropsychiatric Disorders and Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Type (2023-2028)
5 Neuropsychiatric Disorders and Treatment Breakdown Data by Application
    5.1 Global Neuropsychiatric Disorders and Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Neuropsychiatric Disorders and Treatment Market Size (2017-2028)
    6.2 North America Neuropsychiatric Disorders and Treatment Market Size by Country (2017-2022)
    6.3 North America Neuropsychiatric Disorders and Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Neuropsychiatric Disorders and Treatment Market Size (2017-2028)
    7.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2017-2022)
    7.3 Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Neuropsychiatric Disorders and Treatment Market Size (2017-2028)
    9.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2017-2022)
    9.3 Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Astrazeneca
        11.1.1 Astrazeneca Company Detail
        11.1.2 Astrazeneca Business Overview
        11.1.3 Astrazeneca Neuropsychiatric Disorders and Treatment Introduction
        11.1.4 Astrazeneca Revenue in Neuropsychiatric Disorders and Treatment Business (2017-2022)
        11.1.5 Astrazeneca Recent Development
    11.2 Glaxosmithkline
        11.2.1 Glaxosmithkline Company Detail
        11.2.2 Glaxosmithkline Business Overview
        11.2.3 Glaxosmithkline Neuropsychiatric Disorders and Treatment Introduction
        11.2.4 Glaxosmithkline Revenue in Neuropsychiatric Disorders and Treatment Business (2017-2022)
        11.2.5 Glaxosmithkline Recent Development
    11.3 Universal Health Services
        11.3.1 Universal Health Services Company Detail
        11.3.2 Universal Health Services Business Overview
        11.3.3 Universal Health Services Neuropsychiatric Disorders and Treatment Introduction
        11.3.4 Universal Health Services Revenue in Neuropsychiatric Disorders and Treatment Business (2017-2022)
        11.3.5 Universal Health Services Recent Development
    11.4 Boehringer Ingelheim
        11.4.1 Boehringer Ingelheim Company Detail
        11.4.2 Boehringer Ingelheim Business Overview
        11.4.3 Boehringer Ingelheim Neuropsychiatric Disorders and Treatment Introduction
        11.4.4 Boehringer Ingelheim Revenue in Neuropsychiatric Disorders and Treatment Business (2017-2022)
        11.4.5 Boehringer Ingelheim Recent Development
    11.5 Eli Lilly
        11.5.1 Eli Lilly Company Detail
        11.5.2 Eli Lilly Business Overview
        11.5.3 Eli Lilly Neuropsychiatric Disorders and Treatment Introduction
        11.5.4 Eli Lilly Revenue in Neuropsychiatric Disorders and Treatment Business (2017-2022)
        11.5.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Neuropsychiatric Disorders and Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Drug Treatment
    Table 3. Key Players of Shock Treatment
    Table 4. Key Players of Others
    Table 5. Global Neuropsychiatric Disorders and Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Neuropsychiatric Disorders and Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Neuropsychiatric Disorders and Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Neuropsychiatric Disorders and Treatment Market Share by Region (2017-2022)
    Table 9. Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Neuropsychiatric Disorders and Treatment Market Share by Region (2023-2028)
    Table 11. Neuropsychiatric Disorders and Treatment Market Trends
    Table 12. Neuropsychiatric Disorders and Treatment Market Drivers
    Table 13. Neuropsychiatric Disorders and Treatment Market Challenges
    Table 14. Neuropsychiatric Disorders and Treatment Market Restraints
    Table 15. Global Neuropsychiatric Disorders and Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Neuropsychiatric Disorders and Treatment Market Share by Players (2017-2022)
    Table 17. Global Top Neuropsychiatric Disorders and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropsychiatric Disorders and Treatment as of 2021)
    Table 18. Ranking of Global Top Neuropsychiatric Disorders and Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Neuropsychiatric Disorders and Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Neuropsychiatric Disorders and Treatment Product Solution and Service
    Table 22. Date of Enter into Neuropsychiatric Disorders and Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Neuropsychiatric Disorders and Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Neuropsychiatric Disorders and Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Application (2017-2022)
    Table 30. Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Application (2023-2028)
    Table 32. North America Neuropsychiatric Disorders and Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Neuropsychiatric Disorders and Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Astrazeneca Company Detail
    Table 43. Astrazeneca Business Overview
    Table 44. Astrazeneca Neuropsychiatric Disorders and Treatment Product
    Table 45. Astrazeneca Revenue in Neuropsychiatric Disorders and Treatment Business (2017-2022) & (US$ Million)
    Table 46. Astrazeneca Recent Development
    Table 47. Glaxosmithkline Company Detail
    Table 48. Glaxosmithkline Business Overview
    Table 49. Glaxosmithkline Neuropsychiatric Disorders and Treatment Product
    Table 50. Glaxosmithkline Revenue in Neuropsychiatric Disorders and Treatment Business (2017-2022) & (US$ Million)
    Table 51. Glaxosmithkline Recent Development
    Table 52. Universal Health Services Company Detail
    Table 53. Universal Health Services Business Overview
    Table 54. Universal Health Services Neuropsychiatric Disorders and Treatment Product
    Table 55. Universal Health Services Revenue in Neuropsychiatric Disorders and Treatment Business (2017-2022) & (US$ Million)
    Table 56. Universal Health Services Recent Development
    Table 57. Boehringer Ingelheim Company Detail
    Table 58. Boehringer Ingelheim Business Overview
    Table 59. Boehringer Ingelheim Neuropsychiatric Disorders and Treatment Product
    Table 60. Boehringer Ingelheim Revenue in Neuropsychiatric Disorders and Treatment Business (2017-2022) & (US$ Million)
    Table 61. Boehringer Ingelheim Recent Development
    Table 62. Eli Lilly Company Detail
    Table 63. Eli Lilly Business Overview
    Table 64. Eli Lilly Neuropsychiatric Disorders and Treatment Product
    Table 65. Eli Lilly Revenue in Neuropsychiatric Disorders and Treatment Business (2017-2022) & (US$ Million)
    Table 66. Eli Lilly Recent Development
    Table 67. Research Programs/Design for This Report
    Table 68. Key Data Information from Secondary Sources
    Table 69. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neuropsychiatric Disorders and Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Drug Treatment Features
    Figure 3. Shock Treatment Features
    Figure 4. Others Features
    Figure 5. Global Neuropsychiatric Disorders and Treatment Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Research Centres Case Studies
    Figure 9. Neuropsychiatric Disorders and Treatment Report Years Considered
    Figure 10. Global Neuropsychiatric Disorders and Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Neuropsychiatric Disorders and Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Neuropsychiatric Disorders and Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global Neuropsychiatric Disorders and Treatment Market Share by Players in 2021
    Figure 14. Global Top Neuropsychiatric Disorders and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropsychiatric Disorders and Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Neuropsychiatric Disorders and Treatment Revenue in 2021
    Figure 16. North America Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Neuropsychiatric Disorders and Treatment Market Share by Country (2017-2028)
    Figure 18. United States Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Neuropsychiatric Disorders and Treatment Market Share by Country (2017-2028)
    Figure 22. Germany Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Share by Region (2017-2028)
    Figure 30. China Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Neuropsychiatric Disorders and Treatment Market Share by Country (2017-2028)
    Figure 38. Mexico Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Share by Country (2017-2028)
    Figure 42. Turkey Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Astrazeneca Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2017-2022)
    Figure 45. Glaxosmithkline Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2017-2022)
    Figure 46. Universal Health Services Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2017-2022)
    Figure 47. Boehringer Ingelheim Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2017-2022)
    Figure 48. Eli Lilly Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2017-2022)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Astrazeneca
Glaxosmithkline
Universal Health Services
Boehringer Ingelheim
Eli Lilly
Frequently Asked Questions
Neuropsychiatric Disorders and Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neuropsychiatric Disorders and Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neuropsychiatric Disorders and Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Neurosyphilis

Neurosyphilis market is segmented by players, region (country), by Type and by Application. Playe ... Read More

Non Dairy Cheese

The research report includes specific segments by region (country), by company, by Source and by  ... Read More